BLTE – belite bio, inc - american depositary shares (US:NASDAQ)

News

Belite Bio (NASDAQ:BLTE) was given a new $191.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Belite Bio (NASDAQ:BLTE) was downgraded by analysts at Wall Street Zen
Belite Bio (NASDAQ:BLTE) was upgraded by analysts at Wall Street Zen
Has Belite Bio's 134% 2025 Surge Fully Reflected Its DCF and Book Value Picture [Yahoo! Finance]
Belite Bio (NASDAQ:BLTE) was given a new $187.00 price target on by analysts at BTIG Research.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com